Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease
Antioxidants · 28.01.2023 · 12 (2) · 293
DOI: 10.3390/antiox12020293 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 28.01.2023. Verfasst von Mariona Jové und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Lleida Biomedical Research Institute (IRBLleida), Lleida University (UdL), E-25198 Lleida, Spain. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diputació de Lleida, Spanish Ministry of Science, Innovation, and Universities, Generalitat of Catalonia: Department of Health.
Themen: Demenz
Abstract (Originalsprache)
One of the richest tissues in lipid content and diversity of the human body is the brain. The human brain is constitutively highly vulnerable to oxidative stress. This oxidative stress is a determinant in brain aging, as well as in the onset and progression of sporadic (late-onset) Alzheimer’s disease (sAD). Glycerophospholipids are the main lipid category widely distributed in neural cell membranes, with a very significant presence for the ether lipid subclass. Ether lipids have played a key role in the evolution of the human brain compositional specificity and functionality. Ether lipids determine the neural membrane structural and functional properties, membrane trafficking, cell signaling and antioxidant defense mechanisms. Here, we explore the idea that ether lipids actively participate in the pathogenesis of sAD. Firstly, we evaluate the quantitative relevance of ether lipids in the human brain composition, as well as their role in the human brain evolution. Then, we analyze the implications of ether lipids in neural cell physiology, highlighting their inherent antioxidant properties. Finally, we discuss changes in ether lipid content associated with sAD and their physiopathological implications, and propose a mechanism that, as a vicious cycle, explains the potential significance of ether lipids in sAD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Medicine, Lleida Biomedical Research Institute (IRBLleida), Lleida University (UdL), E-25198 Lleida, Spain.
- Research Support Unit (USR), Catalan Institute of Health (ICS), Fundació Institut Universitari per a la Recerca en Atenció Primària de Salut Jordi Gol i Gurina (IDIAP JGol), E-25007 Lleida, Spain.
- Department of Pathology and Experimental Therapeutics, University of Barcelona (UB), E-08907 Barcelona, Spain.
- Neuropathology Group, Institute of Biomedical Research of Bellvitge (IDIBELL), E-08907 Barcelona, Spain.
- Network Research Center of Neurodegenerative Diseases (CIBERNED), Instituto Carlos III, E-08907 Barcelona, Spain.
ORCID-Profile: Mariona Jové, Natàlia Mota-Martorell, Èlia Obis, Joaquim Sol, Meritxell Martín-Garí, Isidre Ferrer, Manuel Portero-Otin, Reinald Pamplona
Förderung
- Diputació de Lleida
- Spanish Ministry of Science, Innovation, and Universities
- Generalitat of Catalonia: Department of Health
- Generalitat of Catalonia: Agency for Management of University and Research Grants
- Institute of Health Carlos III
- Department of Health
- Generalitat of Catalonia: Agency for Management of University and Research
- European Union
Zitieren
APA
Jové, M., Mota-Martorell, N., Obis, È., Sol, J., Martín-Garí, M., Ferrer, I., Portero-Otin, M., & Pamplona, R. (2023). Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease. Antioxidants, 12(2), 293. https://doi.org/10.3390/antiox12020293
Vancouver
Jové M, Mota-Martorell N, Obis È, Sol J, Martín-Garí M, Ferrer I, et al. Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease. Antioxidants. 2023;12(2):293. doi:10.3390/antiox12020293
BibTeX
@article{Jov2023,
author = {Jové, Mariona and Mota-Martorell, Natàlia and Obis, Èlia and Sol, Joaquim and Martín-Garí, Meritxell and Ferrer, Isidre and Portero-Otin, Manuel and Pamplona, Reinald},
title = {Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {2},
pages = {293},
doi = {10.3390/antiox12020293}
}
EUVIMED